Envoy Medical, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Envoy Medical, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $2,916 per $100 of sales comes from others' credit, against $141 tied up three years earlier. Less money tied up than almost all Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-40.6×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 69% of Healthcare companies in United States.
Cash Locked Ratio
−$2,916Money owed to suppliers is larger than money owed by customers plus stock: $2,916 per $100 of sales comes from others' credit, against $141 tied up three years earlier.
Less money tied up than almost all Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +2% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+2% / +235%In 3 years sales changed by +2% while total assets changed by +235%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-104.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than 84% of Healthcare companies in United States.
Cash Cushion Ratio
+6%Cash, after subtracting all debt, equals 6% of its market value (net cash).
Lower than 56% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Envoy Medical, Inc. made a loss over the last year. Envoy Medical, Inc. owes $0.85 for every $1 it owns. Envoy Medical, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEnvoy Medical, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
12.45The share price is 12.45 times Envoy Medical, Inc.'s book value per share, higher than 89% of Healthcare companies in United States.
Market cap
$46 MThe total market value of all of Envoy Medical, Inc.'s shares at today's price (share price × number of shares), smaller than 75% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$4 MWhat Envoy Medical, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.05Net worth divided by the number of shares. The share price of $0.60 is 12.5 times this, which is the P/B above.
Owes vs Owns
0.85×Envoy Medical, Inc. owes $0.85 for every $1 it owns (high), higher than 80% of Healthcare companies in United States.
Dividend yield
NoneEnvoy Medical, Inc. does not currently pay a dividend.
Revenue growth
+7%Revenue rose 7% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Profit growth
LossEnvoy Medical, Inc. made a loss in each of the last two years.
Profit margin
-9857.3%Envoy Medical, Inc. lost $9857 for every $100 of revenue.
Interest cover
Not coveredEnvoy Medical, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashEnvoy Medical, Inc. held $3 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Envoy Medical, Inc.: $46 M ÷ $4 M (30 Jun 2026) = 12.5.
How much does Envoy Medical, Inc. owe compared with what it owns?
Envoy Medical, Inc. owes $0.85 for every $1 it owns (high), higher than 80% of Healthcare companies in United States.
Does Envoy Medical, Inc. pay a dividend?
No. Envoy Medical, Inc. does not currently pay a dividend.
Is Envoy Medical, Inc.'s revenue growing?
Revenue rose 7% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.